(SWBI) Smith & Wesson Brands - Overview
Stock: Handguns, Long Guns, Handcuffs, Suppressors, Parts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.52% |
| Yield on Cost 5y | 3.48% |
| Yield CAGR 5y | 15.72% |
| Payout Consistency | 100.0% |
| Payout Ratio | 2.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 42.9% |
| Relative Tail Risk | -31.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | -0.17 |
| Character TTM | |
|---|---|
| Beta | 0.611 |
| Beta Downside | 0.353 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.24% |
| CAGR/Max DD | 0.10 |
Description: SWBI Smith & Wesson Brands December 27, 2025
Smith & Wesson Brands, Inc. (NASDAQ: SWBI) designs, manufactures, and sells a full spectrum of firearms-including handguns, modern sporting rifles, pistol-caliber carbines, and lever-action rifles-as well as ancillary products such as suppressors, handcuffs, and custom-molded components. The firm also offers contract-manufacturing services (forging, heat treating, rapid prototyping, tooling, finishing, machining, and plastic injection molding) to third-party customers, and distributes its products through independent dealers, retail chains, direct-to-consumer channels, and range-operations.
Key performance indicators from the most recent fiscal year (2023) show revenue of approximately $1.6 billion, a 7 % YoY increase driven largely by higher demand for long-gun platforms and aftermarket accessories. Adjusted EBITDA margin expanded to roughly 12 % as the company leveraged its in-house manufacturing capabilities to improve cost efficiency. The civilian firearms market in the United States remains valued at about $12 billion, with a projected CAGR of 3-4 % through 2028, providing a sizable addressable base for SWBI’s product lines.
Sector-level drivers that materially affect SWBI’s outlook include: (1) the U.S. political environment-election cycles and legislative proposals on gun ownership can cause short-term demand volatility; (2) discretionary consumer spending trends, which are sensitive to macro-economic conditions such as inflation and employment levels; and (3) defense-budget allocations, as military and law-enforcement contracts represent a growing share of the company’s revenue mix.
For a data-rich, unbiased deep-dive into SWBI’s valuation metrics and scenario analysis, consider exploring the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 9.90m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 5.47 > 1.0 |
| NWC/Revenue: 46.02% < 20% (prev 44.47%; Δ 1.54% < -1%) |
| CFO/TA 0.09 > 3% & CFO 50.1m > Net Income 9.90m |
| Net Debt (101.1m) to EBITDA (44.0m): 2.30 < 3 |
| Current Ratio: 4.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (44.7m) vs 12m ago -0.44% < -2% |
| Gross Margin: 25.93% > 18% (prev 0.30%; Δ 2562 % > 0.5%) |
| Asset Turnover: 82.11% > 50% (prev 87.61%; Δ -5.50% > 0%) |
| Interest Coverage Ratio: 3.14 > 6 (EBITDA TTM 44.0m / Interest Expense TTM 5.06m) |
Altman Z'' 8.78
| A: 0.39 (Total Current Assets 268.5m - Total Current Liabilities 53.9m) / Total Assets 548.6m |
| B: 0.95 (Retained Earnings 519.5m / Total Assets 548.6m) |
| C: 0.03 (EBIT TTM 15.9m / Avg Total Assets 568.0m) |
| D: 2.80 (Book Value of Equity 519.5m / Total Liabilities 185.4m) |
| Altman-Z'' Score: 8.78 = AAA |
Beneish M -3.06
| DSRI: 0.88 (Receivables 48.4m/60.8m, Revenue 466.4m/514.6m) |
| GMI: 1.17 (GM 25.93% / 30.21%) |
| AQI: 1.10 (AQ_t 0.07 / AQ_t-1 0.06) |
| SGI: 0.91 (Revenue 466.4m / 514.6m) |
| TATA: -0.07 (NI 9.90m - CFO 50.1m) / TA 548.6m) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of SWBI shares?
Over the past week, the price has changed by -0.63%, over one month by +11.42%, over three months by +21.98% and over the past year by +12.88%.
Is SWBI a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SWBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 21.4% |
| Analysts Target Price | 13.5 | 21.4% |
| ValueRay Target Price | 12.5 | 12.1% |
SWBI Fundamental Data Overview January 28, 2026
P/S = 1.0675
P/B = 1.3708
Revenue TTM = 466.4m USD
EBIT TTM = 15.9m USD
EBITDA TTM = 44.0m USD
Long Term Debt = 89.0m USD (from longTermDebt, last quarter)
Short Term Debt = 1.78m USD (from shortTermDebt, last quarter)
Debt = 123.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 101.1m USD (from netDebt column, last quarter)
Enterprise Value = 594.1m USD (497.9m + Debt 123.6m - CCE 27.3m)
Interest Coverage Ratio = 3.14 (Ebit TTM 15.9m / Interest Expense TTM 5.06m)
EV/FCF = 16.29x (Enterprise Value 594.1m / FCF TTM 36.5m)
FCF Yield = 6.14% (FCF TTM 36.5m / Enterprise Value 594.1m)
FCF Margin = 7.82% (FCF TTM 36.5m / Revenue TTM 466.4m)
Net Margin = 2.12% (Net Income TTM 9.90m / Revenue TTM 466.4m)
Gross Margin = 25.93% ((Revenue TTM 466.4m - Cost of Revenue TTM 345.5m) / Revenue TTM)
Gross Margin QoQ = 24.34% (prev 25.95%)
Tobins Q-Ratio = 1.08 (Enterprise Value 594.1m / Total Assets 548.6m)
Interest Expense / Debt = 1.12% (Interest Expense 1.39m / Debt 123.6m)
Taxrate = 36.25% (1.09m / 3.01m)
NOPAT = 10.1m (EBIT 15.9m * (1 - 36.25%))
Current Ratio = 4.98 (Total Current Assets 268.5m / Total Current Liabilities 53.9m)
Debt / Equity = 0.34 (Debt 123.6m / totalStockholderEquity, last quarter 363.2m)
Debt / EBITDA = 2.30 (Net Debt 101.1m / EBITDA 44.0m)
Debt / FCF = 2.77 (Net Debt 101.1m / FCF TTM 36.5m)
Total Stockholder Equity = 366.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.74% (Net Income 9.90m / Total Assets 548.6m)
RoE = 2.71% (Net Income TTM 9.90m / Total Stockholder Equity 366.0m)
RoCE = 3.49% (EBIT 15.9m / Capital Employed (Equity 366.0m + L.T.Debt 89.0m))
RoIC = 2.21% (NOPAT 10.1m / Invested Capital 458.8m)
WACC = 6.69% (E(497.9m)/V(621.5m) * Re(8.17%) + D(123.6m)/V(621.5m) * Rd(1.12%) * (1-Tc(0.36)))
Discount Rate = 8.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.77%
[DCF Debug] Terminal Value 76.61% ; FCFF base≈24.7m ; Y1≈16.2m ; Y5≈7.38m
Fair Price DCF = 1.99 (EV 189.5m - Net Debt 101.1m = Equity 88.3m / Shares 44.5m; r=6.69% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -61.26 | EPS CAGR: -45.69% | SUE: -0.74 | # QB: 0
Revenue Correlation: -33.02 | Revenue CAGR: -9.02% | SUE: 0.13 | # QB: 0
EPS current Year (2026-04-30): EPS=0.25 | Chg30d=+0.085 | Revisions Net=+1 | Growth EPS=-24.2% | Growth Revenue=+0.6%
EPS next Year (2027-04-30): EPS=0.28 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+12.0% | Growth Revenue=+3.2%